The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MOMENTUM: Phase 3 randomized study of momelotinib (MMB) versus danazol (DAN) in symptomatic and anemic myelofibrosis (MF) patients previously treated with a JAK inhibitor.
 
Ruben A. Mesa
Consulting or Advisory Role - Constellation Pharmaceuticals; La Jolla Pharma; Novartis; Sierra Oncology
Research Funding - Abbvie (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); CTI (Inst); Genentech (Inst); Incyte (Inst); Mays Cancer Center (Inst); NCI (Inst); Promedior (Inst); Samus (Inst)
 
Aaron Thomas Gerds
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Constellation Pharmaceuticals; CTI BioPharma Corp; Novartis; PharmaEssentia; Sierra Oncology
 
Alessandro Vannucchi
Consulting or Advisory Role - Blueprint Medicines; Bristol-Myers Squibb; Incyte; Novartis; Roche
Speakers' Bureau - Abbvie; Blueprint Medicines; Bristol-Myers Squibb; CTI BioPharma Corp; Incyte; Novartis
 
Haifa Kathrin Al-Ali
Honoraria - Abbvie; BMSi; Incyte (Inst); Novartis; Pfizer; Takeda
Consulting or Advisory Role - Abbvie; BMSi; Novartis
Research Funding - BMSi (Inst); Incyte (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - BMSi; Novartis; Novartis
 
David Lavie
Consulting or Advisory Role - Abbvie; BMS; Novartis; Roche; Takeda
 
Andrew T. Kuykendall
Honoraria - Abbvie; Blueprint Medicines; Bristol-Myers Squibb; CTI BioPharma Corp; Novartis
Consulting or Advisory Role - Incyte; Protagonist Therapeutics
Speakers' Bureau - Novartis
Research Funding - Bristol-Myers Squibb; MorphoSys; Prelude Therapeutics; Protagonist Therapeutics; Sierra Oncology
Travel, Accommodations, Expenses - CTI BioPharma Corp
 
Sebastian Grosicki
No Relationships to Disclose
 
Alessandra Iurlo
Honoraria - Celgene/Bristol-Myers Squibb; Incyte; Novartis; Pfizer
Speakers' Bureau - Celgene/Bristol-Myers Squibb; Incyte; Novartis; Pfizer
 
Yeow Tee Goh
Honoraria - Abbvie; Astellas Pharma; Johnson & Johnson/Janssen; MSD; NS Pharma; Roche
Consulting or Advisory Role - Amgen; Antengene; AstraZeneca; EUSA Pharma; Johnson & Johnson/Janssen; Novartis
 
Mihaela Cornelia Lazaroiu
Consulting or Advisory Role - Abbvie; Johnson & Johnson; Novartis; Roche
 
Miklos Egyed
No Relationships to Disclose
 
Maria Laura Fox
Honoraria - Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; OncLive; Sierra Oncology
 
Donal P. McLornan
Speakers' Bureau - Abbvie; Bristol-Myers Squibb; Jazz Pharmaceuticals; Novartis
Research Funding - Celgene/Bristol-Myers Squibb
 
Andrew Perkins
No Relationships to Disclose
 
Sung-Soo Yoon
Honoraria - Novartis
Consulting or Advisory Role - Amgen; Celgene/Jazz; Janssen; Takeda
Research Funding - Kyowa Kirin; Roche/Genentech; Yuhan
 
Vikas Gupta
Honoraria - Abbvie; Bristol-Myers Squibb/Celgene; Constellation Pharmaceuticals; Novartis; Pfizer; Sierra Oncology
Consulting or Advisory Role - Celgene; Novartis; Roche; Sierra Oncology
Research Funding - Novartis (Inst)
 
Jean-Jacques Kiladjian
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Incyte; Novartis; PharmaEssentia
 
Rafe Donahue
Employment - Sierra Oncology
Stock and Other Ownership Interests - Sierra Oncology
Consulting or Advisory Role - Sierra Oncology
Patents, Royalties, Other Intellectual Property - Sierra Oncology
Other Relationship - Sierra Oncology
 
Jun Kawashima
Employment - Kite, A Gilead Company
Stock and Other Ownership Interests - Gilead Sciences
 
Srdan Verstovsek
Consulting or Advisory Role - Celgene; Constellation Pharmaceuticals; Incyte; Novartis; Sierra Oncology
Research Funding - AbbVie (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); Galecto (Inst); Geron (Inst); Incyte (Inst); Kartos Therapeutics (Inst); PharmaEssentia (Inst); Protagonist Therapeutics (Inst); Sierra Oncology (Inst); Telios (Inst)